You mean to tell me that a deceitful CEO who has lied multiple times about the start of the P2B is not to blame for the sell-off? Now that the "imminent" Q2 start is close to be proven yet another lie? R/S, dilution, and clinical trial delays could in no way cause a decline, it must be Greece. Yeah, that's right, Greece.